Lv1
45 积分 2021-11-08 加入
Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials
1个月前
已完结
Additional Findings of 18F-AIF-FAPI-42 PET/CT in a Patient With Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma
2个月前
已完结
Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review
1年前
已完结
CNS progression during vinblastine or targeted therapies for high‐risk relapsed ALK‐positive anaplastic large cell lymphoma: A case series
1年前
已完结
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study
1年前
已完结
Brentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas
1年前
已完结
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial
1年前
已完结
Malignant Melanotic Nerve Sheath Tumor
1年前
已完结
PD-1 inhibitors in patients with Hodgkin lymphoma
1年前
已完结
皖公网安备34019202002308
